Virtual Incision Appoints Jim Alecxih as Chief Executive Officer

Jim Alecxih, CEO, Virtual Incision・ Photo Credit: Virtual Incision

Corporate Business News Sponsored by Business Watch Global

LINCOLN, Neb., June 19, 2025 (VSNewsNetwork.com) — Medical technology company Virtual Incision has announced the appointment of Jim Alecxih as Chief Executive Officer. Alecxih will oversee the company’s efforts to advance the development and commercialization of the MIRA Surgical System and its next-generation platform, M2.

Alecxih brings over 30 years of experience in the medical device industry, including a leadership role at Intuitive Surgical where he contributed to the growth of the da Vinci Surgical System. He has also served as CEO of DH Medical and held executive roles in several healthcare startups and growth-stage companies.

Virtual Incision is preparing for a series of FDA submissions for M2, a miniaturized, single-port surgical robotic system designed to reduce the cost and complexity associated with mainframe cart-based systems. The company aims to expand robotic-assisted surgery to more hospitals, including those in rural and underserved areas.

@VSNewsNetwork

•

@VSNewsNetwork •

“The opportunity to lead Virtual Incision at this pivotal time is an extraordinary honor. I believe deeply in the benefits of robotic-assisted surgery to both patients, surgeons and hospitals. M2 has the potential to dramatically expand access to robotic-assisted surgery in rural hospitals, HOPD and ASC settings, and around the world. Virtual Incision’s visionary approach is to ensure that robotic-assisted surgery is more accessible, flexible and scalable for a broader range of operating environments. I’m thrilled to join this talented team and help accelerate our impact on patients and providers,” said Jim Alecxih, CEO of Virtual Incision.

“We are delighted to welcome Mr. Alecxih to Virtual Incision at this significant stage in the company’s growth. Mr. Alecxih’s exceptional leadership skills and deep industry knowledge make him the ideal person to lead us into our next phase of growth and innovation,” said Tyler Stowater, partner at Bluestem Capital and Virtual Incision board member.

For more information, visit www.virtualincision.com.

Source: Virtual Incision Corporation